"OpenAI, having invested heavily in artificial intelligence, is placing a side bet on organic intelligence. The launderer of training data is participating in the funding of Merge Labs, a maker of brain computer interfaces. "Brain computer interfaces (BCIs) are an important new frontier," the AI biz said on Thursday. "They open new ways to communicate, learn, and interact with technology. BCIs will create a natural, human-centered way for anyone to seamlessly interact with AI. This is why OpenAI is participating in Merge Labs' seed round.""
"The fact that OpenAI CEO Sam Altman is a co-founder of Merge Labs may also have something to do with OpenAI's participation. OpenAI did not disclose the amount of its investment, a portion of the $252 million seed round that also came from investors including Bain Capital and Gabe Newell, co-founder and CEO of Valve. But its financial infusion is inconsequential in light of OpenAI's $1.4 trillion in infrastructure commitments over the next eight years."
OpenAI is participating in the seed funding for Merge Labs, a company developing brain-computer interfaces (BCIs). Merge Labs raised part of a $252 million seed round that included Bain Capital and Gabe Newell. OpenAI CEO Sam Altman is a Merge Labs co-founder. OpenAI did not disclose its investment amount, and the contribution is small relative to OpenAI's $1.4 trillion infrastructure commitments. Morgan Stanley estimated a roughly $400 billion U.S. addressable market for BCIs, primarily for medical uses. Competition includes companies developing invasive and non-invasive BCIs, with near-term healthcare focus and potential future consumer, workplace, and military applications.
Read at Theregister
Unable to calculate read time
Collection
[
|
...
]